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Abstract 
Obesity could be interpreted as a low grade
inflammatory state. The role of cytokines for
innate  and  acquired  immune  response  and
adipocytokines in pathogenesis of obesity is
not  completely  understood.  The  aim  of  the
study was to evaluate anthropometric parame-
ters,  adipocytokines  and  inflammatory
cytokine levels as biomarkers of childhood obe-
sity. This investigation was designed as a lon-
gitudinal  observational  study.  Forty-seven
obese children (19 males and 28 females) were
enrolled by Pediatric Clinic of the Foundation
IRCCS Policlinico San Matteo, Pavia, Italy. For
each patients a blood sample, used for other
biochemical  evaluations,  was  collected.
Cytokines and adipocytokines plasmatic levels
were  determined  using  an  ELISA  method.
Plasma leptin levels are in correlation with age
(r=0.5;  P<0.001)  and  BMI-z  score  (r=0.36;
P<0.001), particularly in girls; plasma resistin
levels are in inverse correlation with age, par-
ticularly in boys (r=-0.67; P<0.001) and in cor-
relation with BMI-z score (r=0.52; P=0.002).
Plasma leptin and resistin levels show a good
correlation with antrophometric parameters of
child obesity (sex and BMI z score). This study
suggests that leptin and resistin can be consid-
ered as biomarker of childhood obesity and its
comorbility. We observed a statistically signifi-
cant  correlation  between  plasma  leptin  and
resistin levels and antrophometric parameters
of child obesity (sex and BMI z score). This
study  suggests  that  adipocytokines,  such  as
leptin and resistin, can be considered as bio-
markers of childhood obesity.
Introduction 
The innate immune system seems to partic-
ipate in the regulation of energy balance and
insulin resistance in response to changes in
the nutritional environment.1 A very interest-
ing feature of the inflammatory response that
emerges in the presence of obesity is that it
appears to be triggered and to reside predomi-
nantly in adipose tissue.2 The deal of white
adipose tissue varied in function of age and
sex and the plasma levels of adipocytokines are
correlated to the grade of obesity. It is impor-
tant to look for a positively correlation between
plasma  cytokines  and  adipocytokines  levels
and  clinical  parameters  of  obesity,  with  the
aim of identify those patients that could pres-
ent in adult age a major risk to develop one or
more of the diseases related to obesity. 
It has also been widely recognised that obe-
sity is a state of low-grade inflammation, with
adipose tissue generating substantial quanti-
ties of pro-inflammatory molecules; the patho-
physiological mechanisms of which remained
poorly  understood,  underlining  the  relation-
ship between adipose tissue and the immune
system. The inflammatory processes are medi-
ated by several factors secreted by adipocytes
collectively called adipocytokines (adiponectin,
leptin, ghrelin, visfatin and resistin) some of
which seem to play an important role in obesi-
ty-associated insulin resistance and cardiovas-
cular complications.3,4
The chronic inflammatory response associ-
ated with obesity is characterized not only by
an abnormal production of adipokines, but also
with an increase in the plasma levels of tumor
necrosis factor-α (TNF-α), interleukin-6 (IL-
6) and other biological markers of inflamma-
tion.  The  increase  in  pro-inflammatory
cytokine  levels,  such  as  TNF-α and  IL-6,  is
partly due to the infiltration of macrophages in
white  adipose  tissue  (WAT).5-7 A  number  of
metabolic  changes  are  caused  by  childhood
obesity, including insulin resistance, diabetes
and dyslipidemia. Lifestyle modification with
changes in dietary habits and physical activity
is the primary intervention suggested to the
patients. Anthropometric parameters may not
identify all positive changes associated with
lifestyle  modifications,  whereas  circulating
adipokines  may  represent  an  alternative  as
biomarkers.
In  this  study  47  simply  obese  pediatric
patients were enrolled by the Department of
Pediatrics  of  the  Pediatric  Clinic  of  IRCCS
Foundation Policlinico S. Matteo. 
The  aim  of  this  study  was  to  investigate
adipocytokines and inflammatory cytokines as
biomarkers  of  metabolic  status  in  childhood
obesity.
Materials and Methods
Aim of the study
In this study we evaluated several clinical
symptoms of obesity and the possible relation-
ship between the low grade inflammatory state
related  to  obesity  and  plasmatic  levels  of
adipocytokines and cytokines. In particular the
aim  of  this  study  was  to  investigate  which
adipocytokine  and  inflammatory  cytokine
could  be  biomarkers  of  metabolic  status  in
childhood obesity.  
Enrollment of patients
Forty-seven simply obese children, 19 boys
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and  28  girls,  presenting  during  2005  to  the
Outpatients’  Department  of  Nutritional
Disorders  of  Pediatric  Clinic  of  IRCCS
Foundation Policlinico San Matteo, Pavia, Italy
were included in the study Multidisciplinary
study of child obesity.
Clinical evaluation
For each patient the study included: com-
plete case-history, clinical evaluation,  formu-
lation of a suitable diet after adeguate exami-
nation, evaluation of plasmatic and serological
immunological  parameters.  Children  with
genetic and endocrine causes of obesity were
excluded.  Clinical  evaluation  included  case-
history and examination to detect secondary
causes of obesity. Moreover an accurate anam-
nesis among the other members of the family
were  conducted  to  identify  possible  familiar
predisposition  to  obesity,  cardiovascular  dis-
eases,  hypertension,  hypercholesterolemia,
endocrine  and  metabolic  disorders.  Clinical
features such as dysmorphism, striae, acan-
thosis  nigricans,  gibbus,  knee  valgus  condi-
tion, flat feet were detected. Body weight was
measured using a standard beam balance to
the nearest 0.1 kg while wearing light indoor
clothing. Body height was measured using a
stadiometer to the nearest 1 mm. BMI was cal-
culated by standard formula (body weight in
kilograms  divided  by  square  of  height  in
meters squared):8 it’s important to remember
that for children and young people (those aged
<18 years), BMI is not a static measurement,
but varies from birth to adulthood, and is dif-
ferent between boys and girls. For this reason
we calculated also BMI z-score, based on the
Center  for  Disease  Control  (CDC)  growth
charts, that seems to be optimal for assessing
adiposity on a single occasion (in according to
international literature, which used a defini-
tion of BMI ≥85th centile of reference data for
overweight and BMI ≥95th centile of reference
data for obesity).8-11
Plasma samples
For  each  patient  a  blood  sample  in
heparinized  syringe  was  collected.  Plasma
sample  was  obtained  after  centrifugation  of
whole blood for 10 min. at 1400 rpm. Plasma
samples were frozen at -20°C until use.
Plasmatic adipocytokines and
cytokines production
Adipocytokines production in plasma sam-
ples was evaluated with an ELISA assay using
a  competition  ELISA  kits  specific  for  each
adipocytokine:  adiponectin  (B-Bridge
International,    Otsuka  Pharmaceutical  Co.,
Ltd.,  Japan),  leptin  (Diagnostics  Biochem,
Canada),  ghrelin  (Phoenix  Pharmaceuticals;
Inc.,  USA),  visfatin  (Phoenix  Pharma  -
ceuticals), resistin (Biovendor). 
Cytokines  production  in  plasma  samples
was evaluated with an ELISA assay according
to  manufacturer  instructions.  Briefly:
microtiter  plates  were  coated  with  purified
monoclonal  antibody  anti-human  IL-6,  IL-8,
TNF-α (respectively  1  ʼg/mL  for  IL-6  and  2
ʼg/mL  for  IL-8,  IL-12,  TNF-α obtained  from
Endogen-Tema,  USA)  and  TGF-β (2  ʼg/mL
obtained from R&D System, USA). After stabi-
lization with 2% BSA (Bovine Serum Albumin,
Sigma) in PBS (Euroclone, Italy) for 1h, sam-
ples  were  added.  Monoclonal  biotin  labeled
antibody anti-human IL-6, IL-8, TNF-α(respec-
tively 0.25 ʼg/mL, 0.05 ʼg/mL, 0.25 ʼg/mL and
0.25 ʼg/mL Endogen) and detection antibody
for TGF-β (300 ng/mL R&D System, USA) were
used.  Reproducibility  and  specificity  of  the
assay were verified previously.
Statistical analysis
The Shapiro-Wilk's W test was used to eval-
uate data distribution. Descriptive results are
presented  as  means  and  SD  or  median  and
interquartile range (25° and 75° percentile).
Inferential  univariate  analysis  using  either
parametric or nonparametric tests were used,
as  appropriate  for  the  data  distribution.
Correlations between parameters were evalu-
ated with the Pearson correlation coefficient.
P<0.05  was  deemed  statistically  significant
and all tests were two-sided. Data analysis was
performed  with  STATA  statistical  package
(Stata Corporation, College Station, Tx, USA).
Results 
Characteristics of the 47 children are sum-
marized in Table 1.
Antrophometric parameters were higher in
boys  compared  to  girls:  mean  boys’  weight
(55.83 kg, SD: 18.81 kg) was higher than mean
girls’ weight (50.75 kg, SD: 19.96 kg); mean
boys’  height  (141.5  cm,  SD:  17.75  cm)  was
higher than mean girls’ height (136.50 cm, SD:
21.46 cm); mean boys’ BMI z-score (2.33, SD:
0.84)  higher  than  mean  girls’  BMI  z-score
(2.07,  SD:  0.52).  History  of  sedentarity  was
present in all children. Family history of obesi-
ty was present in 57% of all subjects. Family
history of cardiovascular diseases was present
in 47% of all subjects and history of hyperten-
sion  in  43%.  Family  history  of  hypercholes-
terolemia was present in 21% of all subjects
and history of endocrine-metabolic disorders,
such  as  diabetes  or  thyroid  disfunctions,  in
40%.  There  was  no  difference  in  clinical
parameters of children with or without family
history  of  obesity.  Considering  all  patients,
23% show striae rubrae, 6% gibbus, 6% acan-
thosis  nigricans,  38%  valgus  condition,  32%
flat feet.
Moreover we considered also pubertal devel-
opment, by physical examination according to
Tanner staging. In particular, we examined the
development of testis and pubic hair for boys
and the breast enlargement and pubic hair for
girls. We considered in pre-pubertal stage (I
Tanner stage) 23 patients (49% of all enrolled
patients), 15 girls (65% of pre-pubertal chil-
dren)  and  8  boys  (35%  of  pre-pubertal  chil-
dren). We considered in pubertal stage (II-III-
IV  Tanner  stage)  24  patients  (51%  of  all
enrolled patients), 13 girls (54% of pubertal
children) and 11 boys (46% of pubertal chil-
dren). BMI was significant higher in all puber-
tal subjects compared to pre-pubertal children
(28.14±4.53  vs  24.87±3.41,  P<0.05,  data  not
shown). We analized correlation between plas-
ma  adipocytokines  levels  and  clinical  vari-
ables, such as age and BMI z score. Plasmatic
leptin levels were in correlation with age and
BMI-z score, particularly in girls (respectively
r=0.5; P<0.001 and r = 0.36; P<0.001) (Figure
1). Plasma resistin levels were in inverse cor-
relation with age, particularly in boys (r=-0.67;
P<0.001) and in correlation with BMI-z score
(r=0.52; P=0.002) (Figure 2).
Plasma  adiponectin,  leptin,  ghrelin  levels
were higher in girls than in boys, even if not
significantly as summarized in Table 2. 
There  is  no  difference  in  plasma  leptin,
adiponectin, ghrelin, resistin and visfatin lev-
els between pre-pubertal and pubertal children
(data not shown). 
We  also  evaluated  plasma  inflammatory
cytokines levels (IL-6, IL-8, TNF-α, TGF-β), but
we  didn’t  observe  a  significant  correlation
between their plasma levels and BMI z-score,
even  if  expressed  with  gender  specification
(Table 2). 
We observed an increment in pro-inflamma-
tory cytokines (IL-6, IL-8, TNF-α)  and TGF-β
production in pubertal children compared to
pre-pubertal children, even if this correlation
is  not  statistically  significant  (data  not
shown).
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Table  1.  Antrophometric  parameters,
expressed as mean and standard deviation,
in both genders.
Total 47
Boys 19
Girls 28
Age, years 9.95 (SD:3.47)
Boys 10.12 (SD:3.44)
Girls 9.74 (SD:3.54)
Weight, kg 52.80 (SD:19.46)
Boys 55.83 (SD:18.81)
Girls 50.75 (SD:19.96)
Heigth, cm 138.52 (SD 19.99)
Boys 141.5 (SD:17.75)
Girls 136.50 (SD:21.46)
BMI z-score 2.18 (SD:0.67)
Boys 2.33 (SD:0.84)
Girls 2.07 (SD:0.52)[page 64] [Pediatric Reports 2010; 2:e19]
Discussion
The etiology of obesity represents a complex
interaction of genetics, diet, metabolism and
physical  activity  levels.  Adipocytokines  and
adipose  tissue  directly  contributes  to  the
pathogenesis  of  obesity  related  disorders.12
Pediatricians should focus preventive efforts
on childhood obesity, with its associated patho-
logic conditions in childhood and likelihood of
persistence into adulthood.13 Obesity runs in
family:14 in our study, about 57% of overweight
and obese children had a family history of obe-
sity.  We  have  evaluated  plasmatic  levels  of
adipocytokines  and  cytokines,  measured  in
basal conditions, in function of clinical param-
eters of obesity, such as sex and body weight.
Leptin has emerged over the past decade as
a key hormone involved in the regulation not
only of food intake and energy expenditure, but
also of neuroendocrine and immune function
as well as in the modulation of glucose and fat
metabolism. Leptin levels correlate whit adi-
posity:  plasmatic  leptin  levels,  that  plays  a
major role in the control of body fat store, with-
in so called brain-gut axis, are so elevated in
obese  patients  to  induce  leptin-resistance.
Leptin levels are closely related to the fat mass
and decrease with weight reduction.15 In our
study we observed a linear correlation of plas-
matic leptin levels with age and BMI-z score,
particularly  in  girls.  Higher  leptin  levels  in
obese girls are attributed to a major production
of subcutaneous adipose tissue, inhibited by
androgen hormones and stimulated by estro-
gen.16 Leptin expression may be increased by
the actions of several inflammatory cytokines,
such as TNF-α and IL-6, as well as by condi-
tions of acute inflammation.17 In this study no
linear correlation was observed between leptin
levels  and  IL-6  or  TNF-α (data  not  shown),
probably because all patients are obese. 
There is considerable controversy about the
role of resistin in humans. Resistin is a protein
hormone  produced  both  by  adipocytes  and
immune  cells  including  those  invading  adi-
pose tissue. Several studies found higher cir-
culating  resistin  levels  and  resistin-mRNA
expression in adipose tissue of obese patients.
Circulating levels of resistin should increase
in obese humans and resistin seems to act on
adipocytes  themselves  leading  to  insulin
resistance.18 In  our  study  plasmatic  resistin
levels  were  in  inverse  correlation  with  age,
particularly in boys, probably related to puber-
tal  hormonal  production,  and  in  correlation
with BMI-z score, as expected.
Adiponectin  levels  in  plasma  uniformly
decrease in obese patients, conferring a sub-
stantially increased risk for obesity comorbidi-
Article
Figure 1. Correlation between plasma leptin levels and age (months) or BMI z score. In
all patients and particularly in girls leptin levels are in correlation with age (respectively,
r=0.30 and r=0.5) and BMI z score (respectively, r=0.31 and 0.35).
Figure 2. Correlation between plasma resistin levels  and age (months) or BMI z score. In
all patients plasma resistin levels are in correlation with age (r=0.42) and BMI z score
(r=0.52); in boys resistin levels are in stronger correlation with age (r = -0.67) and BMI
z score (r=0.8).
Table  2.  Plasmatic    adipocytokines  and
inflammatory cytokines levels.
Adipocytokines
Leptin, ng/mL 48.45 (SD 41.49)
Boys 44.29 (SD 23.62)
Girls 52.42 (SD 51.46)
Adiponectin, ng/mL 17.14 (SD 7.16)
Boys 15.62 (SD 7.19)
Girls 18.41 (SD 7.07)
Visfatin, ng/mL 9.08 (SD 3.03)
Boys 9.33 (SD 2.66)
Girls 8.92 (SD 3.32)
Resistin, ng/mL 3.01 (SD 1.17)
Boys 3.05 (SD 1.50)
Girls 2.97 (SD 0.85)
Grelin, ng/mL 2.20 (SD 0.90)
Boys 1.92 (SD 1.00)
Girls 2.47 (SD 0.74)
Inflammatory citokines
IL6, pg/mL 1.12 (IQR: 0.13-4.34)
Boys 2.425 (IQR: 0.62-16.34)
Girls 0.93 (IQR: 0.05-2.13)
TNFα, pg/mL 0.88 (IQR: 0.68-1.37)
Boys 0.86 (IQR: 0.69-1.78)
Girls 0.91 (IQR: 0.67-1.34)
IL8, pg/mL 17.16 (IQR: 13.43-21.69)
Boys 18.06 (IQR: 13.8-22.76)
Girls 16.64 (IQR: 13.25-20.83)
TGFβ, pg/mL,  18419 (IQR: 12121-27977.5)
Boys 16012 (IQR: 12552-19819)
Girls 19856.5 (IQR: 11608.5-28780)[Pediatric Reports 2010; 2:19] [page 65]
ty.  Circulating  adiponectin  may  represent  a
good  biomarker  to  evaluate  the  efficacy  of
lifestyle intervention in overweight/obese chil-
dren.  Adiponectin  levels  are  lower  in  obese
children  whereas  markers  of  inflammation
and  pro-inflammatory  cytokines  are  higher:
hypoadiponectemia may contribute to the low-
grade  systemic  chronic  inflammatory  state
associated with childhood obesity.19 We didn’t
observe a significant correlation between plas-
ma  adiponectin  levels  and  BMI  z  score.
Plasmatic  adiponectin  levels  were  higher  in
girls than in boys, as previously shown by other
authors.20-22 Plasma  concentration  of  total
adiponectin were also inversely related to age,
as Sabin et al. demonstrated,23 even if not sig-
nificantly (data not shown).
Visfatin  appears  to  be  preferentially  pro-
duced by visceral adipose tissue, has insulin-
mimetic  action  and  was  also  identified  in
inflammatory cells.24 Visfatin plasma concen-
tration seems to be positively correlated with
the  visceral  visfatin-mRNA  expression  and
percentage of body fat, but negatively with sub-
cutaneous  visfatin  mRNA  expression,  as
Berndt et al. suggested.25 This effect probably
becomes evident only in more advanced age:
children abdominal fat mass is indeed lower
than in adulthood and it’s not able to influence
visceral visfatin-mRNA expression. As expect-
ed in pediatric patients, we didn’t observe any
significant correlation between visfatin plas-
matic concentration and BMI z-score. 
Ghrelin is implicated in the coordination of
energy balance and weight regulation and its
regulation seems to be an important factor in
the  pathogenesis  of  obesity.  Mechanism  of
appetite and energy metabolism are mediated
through  hormones,  leptin  and  ghrelin,  neu-
ropeptide Y as well as genetic factors.26 In our
study we didn’t find a significant correlation
between plasma ghrelin levels and age or gen-
der, as previously shown by Zou et al.27
Obesity  and  correlated  metabolic  patholo-
gies are associated with a chronic  inflamma-
tory  response,  characterized  by  abnormal
cytokine  production.  Macrophage  infiltration
of adipose tissue is characteristic of human
obesity. These cells appear to be activated both
from a morphologic (giant cells) and function-
al (cytokine production) standpoint. Circulat  -
ing levels of TNF-α and IL-6 are directly corre-
lated with adiposity.28 Reduction in fat mass
correlates with decrease in the plasma levels of
many of these cytokines.29 IL-6 seems to play
an important role in the adipose tissue physi-
ology and is believed to be a link between obe-
sity,  insulin  resistance  and  endothelial  dys-
function.30 Moreover, IL-6 and other mediators
of  innate  immunity  can  interact  with  leptin
that regulates energy balance through a wide
range of functions, including several that are
important  to  cardiovascular  health.31 The
propensity to produce more IL6 could be relat-
ed to the higher levels of leptin observed in
plasma of obese children. TNF-α has been pro-
posed as a link between obesity and insulin
resistance because TNF-α is overexpressed in
obese animals’ and humans’ adipose tissue,
and  obese  mice  lacking  either  TNF-α or  its
receptor  show  protection  against  developing
insulin resistance.32 The circulating levels of
several acute-phase proteins and inflammatory
cytokines led to the view that obese patients
are  characterised  by  a  state  of  chronic  low-
grade inflammation, and that this links causal-
ly to insulin resistance and the metabolic syn-
drome.33
In conclusion, despite the great advances in
our  knowledge  of  adipose  tissue  physiology,
many areas of investigation remain. Anthro  -
pometric parameters may not identify all posi-
tive changes associated with lifestyle modifi-
cations,  whereas  circulating  adipokines  may
represent an alternative as biomarkers. This
study suggests that leptin and resistin levels
are  correlated  with  age  and  BMI  z  score  in
obese children. These adipocytokines can be
considered as markers of metabolic outcomes
in childhood obesity and further studies could
be  important  to  find  new  molecules  in  the
adipocytokines pathway, that can be useful in
treatment of  obesity and its related disorders.
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